BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34398470)

  • 1. Impact of radiation therapy facility volume on survival in patients with cancer.
    Tchelebi LT; Shen B; Wang M; Gusani NJ; Walter V; Abrams R; Verma V; Zaorsky NG
    Cancer; 2021 Nov; 127(21):4081-4090. PubMed ID: 34398470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.
    Bergquist JR; Thiels CA; Shubert CR; Habermann EB; Hayman AV; Zielinski MD; Mathis KL
    World J Surg; 2016 Feb; 40(2):447-55. PubMed ID: 26566779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Facility Surgical Volume on Survival in Patients With Cancer.
    Stoltzfus KC; Shen B; Tchelebi L; Trifiletti DM; Gusani NJ; Walter V; Wang M; Zaorsky NG
    J Natl Compr Canc Netw; 2021 May; 19(5):495-503. PubMed ID: 33561825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
    Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.
    Amin S; Baine M; Meza J; Lin C
    BMC Cancer; 2021 Apr; 21(1):387. PubMed ID: 33836694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
    Patel SA; Goyal S; Liu Y; Moghanaki D; Patel PR; Hanasoge S; Dhere VR; Shelton JW; Godette KD; Jani AB; Hershatter B; Fischer-Valuck BW
    JAMA Netw Open; 2020 Dec; 3(12):e2025143. PubMed ID: 33301015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cassidy RJ; Liu Y; Patel K; Zhong J; Steuer CE; Kooby DA; Russell MC; Gillespie TW; Landry JC
    Cancer; 2017 Mar; 123(5):783-793. PubMed ID: 27780316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
    Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
    Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study.
    Abdel-Rahman O; Kumar A; Kennecke HF; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2018 Mar; 17(1):e21-e28. PubMed ID: 28709877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
    Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
    Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Kuan FC; Lai CH; Ku HY; Wu CF; Hsieh MC; Liu TW; Yeh CY; Lee KD
    Int J Cancer; 2017 Apr; 140(7):1662-1669. PubMed ID: 27935051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
    Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
    Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Goshtasbi K; Abiri A; Lehrich BM; Haidar YM; Tjoa T; Kuan EC
    Head Neck; 2021 Sep; 43(9):2755-2763. PubMed ID: 33998094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Treatment Coordination on Overall Survival in Rectal Cancer.
    Biju K; Zhang GQ; Stem M; Sahyoun R; Safar B; Atallah C; Efron JE; Rajput A
    Clin Colorectal Cancer; 2021 Sep; 20(3):187-196. PubMed ID: 33618972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.